RPX Corp. (NASDAQ:RPXC) insider Mallun Yen sold 5,000 shares of RPX Corp. stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $10.00, for a total transaction of $50,000.00. Following the sale, the insider now directly owns 100,722 shares of the company’s stock, valued at $1,007,220. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Mallun Yen also recently made the following trade(s):

  • On Tuesday, August 23rd, Mallun Yen sold 8,155 shares of RPX Corp. stock. The stock was sold at an average price of $10.63, for a total transaction of $86,687.65.

Shares of RPX Corp. (NASDAQ:RPXC) opened at 10.72 on Monday. The firm has a 50-day moving average of $10.22 and a 200 day moving average of $10.08. RPX Corp. has a 1-year low of $8.60 and a 1-year high of $14.09. The company has a market capitalization of $526.91 million, a P/E ratio of 25.58 and a beta of 1.78.

RPX Corp. (NASDAQ:RPXC) last announced its quarterly earnings data on Thursday, November 3rd. The company reported $0.25 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.02. The firm earned $88.50 million during the quarter, compared to analysts’ expectations of $87.25 million. RPX Corp. had a net margin of 6.80% and a return on equity of 5.47%. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.19 earnings per share. On average, analysts anticipate that RPX Corp. will post $0.74 EPS for the current year.

Insider Buying and Selling by Quarter for RPX Corp. (NASDAQ:RPXC)

RPXC has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of RPX Corp. from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a report on Saturday, August 6th. Cowen and Company lowered their price target on shares of RPX Corp. from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, November 4th.

Institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its position in RPX Corp. by 2.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,100,969 shares of the company’s stock valued at $28,435,000 after buying an additional 61,109 shares during the last quarter. Boston Partners boosted its position in RPX Corp. by 6.7% in the third quarter. Boston Partners now owns 1,894,131 shares of the company’s stock valued at $20,248,000 after buying an additional 118,499 shares during the last quarter. Renaissance Technologies LLC boosted its position in RPX Corp. by 27.5% in the first quarter. Renaissance Technologies LLC now owns 1,707,500 shares of the company’s stock valued at $19,226,000 after buying an additional 368,700 shares during the last quarter. Acadian Asset Management LLC boosted its position in RPX Corp. by 0.7% in the third quarter. Acadian Asset Management LLC now owns 1,641,856 shares of the company’s stock valued at $17,552,000 after buying an additional 11,421 shares during the last quarter. Finally, BlackRock Fund Advisors boosted its position in RPX Corp. by 5.2% in the third quarter. BlackRock Fund Advisors now owns 1,278,178 shares of the company’s stock valued at $13,664,000 after buying an additional 62,741 shares during the last quarter. 85.98% of the stock is owned by institutional investors.

About RPX Corp.

RPX Corporation offers patent risk management solutions. The Company’s patent risk management solution facilitates exchanges of value between owners and users of patents. The core of its solution is defensive patent aggregation, in which the Company acquires patents and licenses to patents that are being or may be asserted against its clients.

5 Day Chart for NASDAQ:RPXC

Receive News & Stock Ratings for RPX Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPX Corp. and related stocks with our FREE daily email newsletter.